Interested in learning more about the Catalyze program? Join us on March 19 at 12pm ET for a live webinar where a panel of four funded investigators will describe their Catalyze project and summarize key takeaways from the program. Time will be reserved for audience questions. March...
https://wisconsinctc.org/client-successes/cell-logistics/...
https://innovate.wisc.edu/partnership-accelerates-transition-of-uw-madison-technologies-from-lab-to-market/ ...
Madison, WI, January 9, 2024 – Cellular Logistics Inc. (CL) in Madison, Wisconsin, and Allele Biotechnology Inc. (ALLELE) in San Diego, California, have entered a collaboration to develop regenerative medicine products to treat ischemic heart disease. The relationship has been recently bolstered by the Catalyze award that...
Cellular Logistics Receives Second SBIR Advance Award...
MADISON, Wis., October 24, 2022 – Cellular Logistics has been awarded a $337,000 SBIR grant from the National Institutes of Health to further evaluate the functional immune and angiogenic (blood vessel growth) responses of the company's Cardiac Fibroblast Matrix product, CFX™ Solus, for the treatment...
New study identifies protein essential to form stem cell-derived human heart cells...
MADISON, WI, May 16, 2022 – Cellular Logistics, a Madison, Wisconsin company that is creating a new way to restore heart function and help patients with heart damage is launching a new financing round to advance its product, Tandem™, to the next stage of product development, and moving...
MADISON, WI, May 10, 2022 – Cellular Logistics, a Madison-area company that is creating a new way to restore heart function and help patients with heart damage has been chosen to present at the Midwest Growth Capital Symposium (MGCS) being held on May 17-18, 2022. 2022...
Cellular Logistics Receives Commercialization Funding...